Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance.
Kendall
Tim
T
National Collaborating Centre for Mental Health, Research and Training Unit, London E1 8AA.
Taylor
Eric
E
Perez
Alejandra
A
Taylor
Clare
C
D000293:Adolescent; D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use; D000328:Adult; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis* / Q000628:therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003376:Counseling; D004032:Diet; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use; D010290:Parents / Q000193:education; D017410:Practice Guidelines as Topic; D011437:Propylamines / Q000627:therapeutic use; D013663:Teaching / Q000379:methods
D018759:Adrenergic Uptake Inhibitors; D000697:Central Nervous System Stimulants; D011437:Propylamines; D008774:Methylphenidate; D000069445:Atomoxetine Hydrochloride